for now. All the moving averages are 6 -something. So it's been going sideways for quite a while now.
I was hoping it would get cheaper.
The fact that all trial participants requested their other eye be injected is very good anecdotal, (non-scientific) evidence of the value of the RPE therapy.
People want this. And in a way, that's all that matters when you're selling something.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.